Evidence map›Paper›PMID 19959641›Full record

ArticleInvestigative ophthalmology & visual science2010

Tear lipocalin captures exogenous lipid from abnormal corneal surfaces.

Ben J Glasgow, Oktay K Gasymov, Adil R Abduragimov, Jamison J Engle, Richard C Casey

Open access · bronzeAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Evidence for Phospholipids on the Surface of Human Tears.Investigative ophthalmology & visual science · 2020
    Article
  3. Ligand binding complexes in lipocalins: Underestimation of the stoichiometry parameter (n).Biochimica et biophysica acta. Proteins and proteomics · 2018
    Article
  4. Interaction of ceramides and tear lipocalin.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2018
    Article
  5. Article
  6. Article
  7. Practical issues concerning tear protein assays in dry eye.Eye and vision (London, England) · 2014
    Review
  8. Article
  9. Tear film lipids.Experimental eye research · 2013
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Tear lipocalin: structure and function.The ocular surface · 2011
    Review
  16. Article
  17. Focus on molecules: tear lipocalin.Experimental eye research · 2011
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ben J GlasgowDepartments of Pathology, UCLA School of Medicine, Los Angeles, California, USA. bglasgow@mednet.ucla.edu
Oktay K Gasymov
Adil R Abduragimov
Jamison J Engle
Richard C Casey
University of California, Los Angeles · US

Funding

Vision Research Core at UCLAP30EY000331 · NEI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Gregory Darin Field, DAVID S WILLIAMS · 1985 to 2026
$16.8M
Proteins in the Molecular Mechanisms of Tear Film FormationR01EY011224 · NEI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GLASGOW, BEN J · 2001 to 2020
$6.8M
PROTEINS IN MOLECULAR MECHANISMS OF TEAR FILM FORMATIONR29EY011224 · NEI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GLASGOW, BEN J · 1996 to 2000
$116k
NEI NIH HHS EY00331NEI NIH HHS EY11224NEI NIH HHS P30 EY000331NEI NIH HHS R01 EY011224NEI NIH HHS R29 EY011224
6 · The paper itself

Abstract

Purpose. The cornea is protected by apical hydrophilic transmembrane mucins and tears. In pathologic states the mucin barrier is disrupted, creating potential for meibomian lipids to adhere more strongly. Undisplaced lipids create an unwettable surface. The hypothesis that pathologic ocular surfaces alter lipid binding and the ability of tear proteins to remove lipids was tested. Methods. Corneas with pathologic surfaces were studied for lipid adhesion and removal by tears. Capture of fluorescence-labeled phospholipids by human tears was assessed by steady state fluorometry. Tear proteins were separated by gel filtration chromatography and analyzed for bound lipids. Results. Contact angle measurements revealed strong lipid adherence to corneas submerged in buffer. Lower contact angles are observed for lipids on completely de-epithelialized corneas compared with intact corneas (P = 0.04). Lipid removal from these surfaces is greater with whole tears than with tears depleted of tear lipocalin (P < 0.0005). Significantly fewer lipids are captured by tears from Bowman's layer than from epithelial-bearing surfaces (P < 0.025). The only tear component to bind the fluorescence-tagged lipid is tear lipocalin. The histology of a rare case of dry eye disease demonstrates the dominant features of contemporaneous bullous keratopathy. Lipid sequestration from this cornea by tear lipocalin was robust. Conclusions. Lipid is captured by tear lipocalin from corneas with bullous keratopathy and dry eye. Lipid removal is slightly abrogated by greater lipid adhesion to Bowman's layer. Reduced secretion of tear lipocalin documented in dry eye disease could hamper lipid removal and exacerbate ocular surface pathology.

Indexed as

Lipid MetabolismCarrier ProteinsChromatography, GelCorneal DiseasesDebridementDry Eye SyndromesElectrophoresis, Polyacrylamide GelEpithelium, CornealEye ProteinsFluorescent DyesFluorophotometryHumansLipocalin 1Membrane LipidsSpectrometry, FluorescenceCarrier ProteinsEye ProteinsFluorescent DyesLipocalin 1Membrane Lipidstear proteins

Identifiers

PMID19959641
PMCPMC2868392
OpenAlexW2001333381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.